Psagot Value Holdings Ltd. Takeda Pharmaceutical CO LTD Transaction History

Psagot Value Holdings Ltd.

Previous 0 NaN%

Previous $0 NaN%

100.0%

Previous 100.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 09, 2024	BUY	$13.0 - $15.08 $0 - $0	0 New	0 $0
Q2 2024 Aug 14, 2024	SELL	$12.6 - $13.67 $151,149 - $163,985	-11,996 Closed	0 $0
Q1 2024 May 15, 2024	SELL	$13.89 - $15.04 $450,452 - $487,747	-32,430 Reduced 73.0%	11,996 $167,000
Q4 2023 Feb 08, 2024	SELL	$13.36 - $15.43 $20,935 - $24,178	-1,567 Reduced 3.41%	44,426 $632,000
Q3 2023 Oct 30, 2023	SELL	$15.03 - $16.32 $231,462 - $251,328	-15,400 Reduced 25.08%	45,993 $715,000
Q2 2023 Aug 03, 2023	SELL	$15.57 - $17.11 $1.76 Million - $1.93 Million	-112,907 Reduced 64.78%	61,393 $964,000
Q1 2023 Jun 20, 2023	BUY	$15.28 - $16.48 $2.66 Million - $2.87 Million	174,300 New	174,300 $2.83 Million

332

73.7M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $40.4B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Psagot Value Holdings Ltd. , based on Form 13F filings with the SEC.

Stay updated on Psagot Value Holdings Ltd. with notifications on news.